IGF2BP1 and hepatocellular carcinoma: These results indicated that IGF2BP1 overexpression significantly impaired the silencing KDM5B-mediated decrease in cell proliferation (Fig. 6A–D), invasion, and migration in HCC cells (Fig. 6E–G).